期刊文献+

肝移植术中凝血因子监测及出凝血药物的应用 被引量:2

原文传递
导出
摘要 随着临床外科学、麻醉学及输血学等学科的发展,肝移植的成功率有很大提高,病人术后生存时间明显延长。国外文献报道1年存活率为80%~90%,最长生存时间超过26年。由于接受肝脏移植的多为终末期肝病病人,围手术期的出血是临床上面临的棘手问题。因此,充分的准备及术中、术后完善的止凝血实验室监测,及时、合理地使用血液及其制品治疗,是手术成功的关键。
出处 《中华肝胆外科杂志》 CAS CSCD 2006年第2期122-124,共3页 Chinese Journal of Hepatobiliary Surgery
  • 相关文献

参考文献8

  • 1Hendriks HGD,Meijer K,Dewolf ITM,et al.Detection of the influence of recombinant factor Ⅶ a on coagulation by thromboelastography in liver trans-plantation.Blood coagulation and fibrinolysis,2002,13:309-313.
  • 2Porte RJ,Molenaar IQ,Begliomini B,et al.Aprotinin and transfusion requirements in orthotopic liver transplantation:a multicentre randomised double-blind study.EMSALT Study Group.Lancet,2000,355:1303-1309.
  • 3Kalicicinnski A,Drewnisk T.Quick correction of hemostasis in two patients with fulminant liver failure undergoing liver transplantation by recombinant activated factor Ⅶ.Transplant Proc,1999,31:378.
  • 4Bindi ML,Biancofiore GD,Consani G,et al.Blood coagulation monitoring during liver transplantation:sonoclot analysis and laboratory tests.Minerva Anestesiol,2001,7:359-369.
  • 5Dupont J,Messiant F,Declerck N,et al.Liver transplantation without the use of fresh frozen plasma.Anesth Analg,1996,83:681-686.
  • 6Molenaar IQ,Legnani C,Groenland TH,et al.Aprotinin in orthotopic liver transplantation:evidence for a prohemostatic,but not a prothrombotic,effect.Liver Transpl,2001,7:896-903.
  • 7Marcel RJ,Stegall WC,Suit CT,et al.Continuous small-dose aprotinin controls fibrinolysis during orthotopic liver transplantation.Anesth Analg,1996,82:1122-1125.
  • 8Frenette L,Cox J,Arnall M,et al.Effectiveness of conjugated estrogen in orthotopic liver transplantation.South Med J,1998,91:365-368.

同被引文献28

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部